Enrofloxacin,Ciprofloxacin antibody

Catalog No. ABIN111400

This Mouse Monoclonal antibody specifically detects Enrofloxacin,Ciprofloxacin in EIA. It exhibits reactivity toward Campylobacter.

Quick Overview for Enrofloxacin,Ciprofloxacin antibody (ABIN111400)

Target: Enrofloxacin,Ciprofloxacin

Reactivity: Campylobacter

Host: Mouse

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Enzyme Immunoassay (EIA)

Clone: 72FIG1F7#1

Product Details

Purification: Purified

Immunogen: Enrofloxacin conjugated to KLH (keyhole limpet hemocyanin) via carbodiimide

Isotype: IgM

Application Details

Application Notes: Suitable for use in ELISA.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Concentration: 1.0 mg/mL (OD280 nm)

Buffer: PBS buffer, pH 7.4 without preservatives

Preservative: Without preservative

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Target Details

Target: Enrofloxacin,Ciprofloxacin

Background: Enrofloxacin is a fluoroquinolone that inhibits the activity of bacterial DNA gyrase. It was the first fluoroquinolone antimicrobial to be used in veterinary infections by E. coli, Salmonella, Pasteurella, Mycoplasma and Hemophilus species. Ciprofloxacin, a fluoroquinolone, is a concentration dependent bactericidal agent. It is structurally related to enrofloxacin, and has a similar spectrum of activity. Both of these antimicrobials have shown activity against some gram positive aerobes and a wide range of gram negative bacilli and cocci, which include Klebsiella, Pseudomonas, Salmonella, and other organisms such as Mycoplasma, Staphylococci and Chlamydia. Due to the fluoroquinolone's variable activity against most Streptococci, as well as their weak activity against many anaerobic bacteria, they are generally not recommended for use in treating infections where these types of microbes are present. Like enrofloxacin, ciprofloxacin is believed to act by inhibiting bacterial DNA gyrase which prevents DNA supercoiling and DNA synthesis.